Abstract
Nanopore sequencing is a method for determining the order and modifications of DNA/RNA nucleotides by detecting the electric current variations when DNA/RNA oligonucleotides pass through the nanometer-sized hole (nanopore). Nanopore-based DNA analysis techniques have been commercialized by Oxford Nanopore Technologies, NabSys, and Sequenom, and widely used in scientific researches recently including human genomics, cancer, metagenomics, plant sciences, etc., moreover, it also has potential applications in the field of healthcare due to its fast turn-around time, portable and real-time data analysis. Those features make it a promising technology for the point-of-care testing (POCT) and its potential clinical applications are briefly discussed in this chapter.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Norris AL, Workman RE, Fan YF et al (2016) Nanopore sequencing detects structural variants in cancer[J]. Cancer Biol Ther 17(3):246–253
Gong L, Wong C, Cheng W et al (2017) Nanopore sequencing reveals high-resolution structural variation in the cancer genome[J]. bioRxiv
Sanchisjuan A, Stephens J, French C et al (2018) Complex structural variants in Mendelian disorders: identification and breakpoint resolution using short- and long-read genome sequencing[J]. Genome Med 10(1):1–10
Miao HF, Zhou JP, Yang Q et al (2018) Long-read sequencing identified a causal structural variant in an exome-negative case and enabled preimplantation genetic diagnosis. Hereditas 155(32)
Mitsuhashi S, Frith MC, Mizuguchi T et al (2019) Tandem-genotypes: robust detection of tandem repeat expansions from long DNA reads[J]. Genome Biol 20(1):58
Stancu MC, Van Roosmalen MJ, Renkens I et al (2017) Mapping and phasing of structural variation in patient genomes using nanopore sequencing[J]. Nat Commun 8(1):1326–1338
Au CH, Dona N, Beca B (2019) K. Ip et al. Rapid detection of chromosomal translocation and precise breakpoint characterization in acute myeloid leukemia by nanopore long-read sequencing. Cancer Genet 239:22–25
Soda M, Choi YL, Enomoto M et al (2007) Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancerJ. Nature 448(7153):561–566
Jain M, Olsen HE, Paten B et al (2016) The Oxford Nanopore MinION: delivery of nanopore sequencing to the genomics communityJ. Genome Biol 17(1):239
Nanopore Protocol 1D Sequence capture (SQK-LSK108)
Jain M, Fiddes IT, Miga KH et al (2015) Improved data analysis for the MinION nanopore sequencer[J]. Nat Methods 12(4):351
Oxford Nanopore Technologies. Incorporating sequence capture into library preparation for MinION GridION and PromethION. Online. Available at: https://nanoporetech.com/resource-centre/incorporating-sequence-capture-library-preparation-minion-gridion-and-promethion. Accessed 29 August, 2019
Leija‐Salazar M et al (2019) Evaluation of the detection of GBA missense mutations and other variants using the Oxford Nanopore MinION. Mol Genet Genomic Med 7(3):e564
Gilpatrick T et al (2019) Targeted nanopore sequencing with Cas9 for studies of methylation, structural variants, and mutations. BioRxiv:604173
Mesri E, Feitelson MA, Munger K (2014) Human viral oncogenesis: a cancer Hallmarks analysis. Cell Host Microbe 15(3):266–282
Plummer M, Martel CD, Vignat J, Ferlay J, Bray F, Franceschi S (2016) Global burden of cancers attributable to infections in 2012: a synthetic analysis. Lancet Glob Health 4(9):e609–e616
Tashiro H, Brenner MK (2017) Immunotherapy against cancer-related viruses. Cell Res 27(1):59–73
Tuna M, Amos CI (2017) Next generation sequencing and its applications in HPV-associated cancers. Oncotarget 8(5):8877
Strong MJ, Tina OG, Zhen L, Guorong X, Melody B, Chris P, Kun Z, Taylor CM, Flemington EK (2013) Epstein-Barr virus and human herpesvirus 6 detection in a non-Hodgkin’s diffuse large B-cell lymphoma Cohort by using RNA sequencing. J Virol 87(23):13059–13062
Tang KW, Alaeimahabadi B, Samuelsson T, Lindh M, Larsson E (2013) The landscape of viral expression and host gene fusion and adaptation in human cancer. Nat Commun 4(2513):2513
Network CGA (2014) Comprehensive molecular characterization of gastric adenocarcinoma. Nature 513(7517):202–209
Network CGA (2014) Comprehensive molecular characterization of urothelial bladder carcinoma. Nature 507(7492):315–322
Network CGA (2015) Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature 517(7536):576
Cantalupo PG, Katz JP, Pipas JM (2017) Viral sequences in human cancer. Virology 513:208–216
Hanahan D, Weinberg R (2011) Hallmarks of cancer: the next generation. Cell 144(5):646–674
Agalioti T, Lomvardas S, Parekh AB, Yie J, Maniatis T, Thanos D, Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100(1):57–70
Gutschner T, Diederichs S (2012) The hallmarks of cancer. RNA Biol 9(6):703–719
Xu M, Zhang WL, Zhu Q, Yao YY, Feng QS, Zhang Z, Peng RJ, Jia WH, He GP, Feng L (2019) Genome-wide profiling of Epstein-Barr virus integration by targeted sequencing in Epstein-Barr virus associated malignancies. Theranostics 9(4):1115
Murakami Y, Saigo K, Takashima H, Minami M, Okanoue T, Bréchot C, Paterlinibréchot P (2005) Large scaled analysis of hepatitis B virus (HBV) DNA integration in HBV related hepatocellular carcinomas. Gut 54(8):1162–1168
Pett M, Coleman N (2010) Integration of high-risk human papillomavirus: a key event in cervical carcinogenesis? J Pathol 212(4):356–367
Pinatti LM, Walline HM, Carey TE (2018) Human papillomavirus genome integration and head and neck cancer. J Dent Res 97(6):691–700
Zhang J, Huang T, Zhou Y, Cheng A, Yu J, To KF, Kang W (2018) The oncogenic role of Epstein-Barr virus-encoded microRNAs in Epstein-Barr virus-associated gastric carcinoma. J Cell Mol Med 22(1):38–45
Symons J, Cameron PU, Lewin SR (2018) HIV integration sites and implications for maintenance of the reservoir. Curr Opin HIV and AIDS 13(2):152
Ameur A, Kloosterman WP, Hestand MS (2019) Single-molecule sequencing: towards clinical applications. Trends Biotechnol 37(1):72–85
Madsen EB, Kvist T, Höijer I, Ameur A, Mikkelsen MJ (2018) Xdrop: targeted sequencing of long DNA molecules from low input samples using droplet sorting. bioRxiv:409086
Artesi M, Hahaut V, Ashrafi F, Marçais A, Hermine O, Griebel P, Arsic N, van der Meer F, Burny A, Bron D et al (2019) Pooled CRISPR Inverse PCR sequencing (PCIP-seq): simultaneous sequencing of retroviral insertion points and the associated provirus in thousands of cells with long reads. bioRxiv:558130
Wang M, Beck CR, English AC, Meng Q, Buhay C, Han Y, Doddapaneni HV, Yu F, Boerwinkle E, Lupski JR (2015) PacBio-LITS: a large-insert targeted sequencing method for characterization of human disease-associated chromosomal structural variations. BMC Genomics 16(1):214
Mamanova L, Coffey AJ, Scott CE, et al. (2010) Target-enrichment strategies for next-generation sequencing (vol 7, pg 111) [J]. Nat Methods 7(6):479–479
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Sun, X. et al. (2020). Nanopore Sequencing and Its Clinical Applications. In: Huang, T. (eds) Precision Medicine. Methods in Molecular Biology, vol 2204. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-0904-0_2
Download citation
DOI: https://doi.org/10.1007/978-1-0716-0904-0_2
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-0903-3
Online ISBN: 978-1-0716-0904-0
eBook Packages: Springer Protocols